Rare diseases
Investigational molecules
Locations
Rm 519 5 F 29 Jungang Ro, Gyeonggi Do, 17894
Canariabio Inc. focuses on advanced epithelial ovarian carcinoma, with related interest in fallopian tube cancer and primary peritoneal carcinoma. The company’s clinical activity is centered on treatment strategies for newly diagnosed advanced disease after debulking surgery.
Its research landscape is concentrated on gynecologic malignancies requiring systemic therapy in the advanced setting.
Canariabio Inc. runs clinical trials in conditions such as Malignant peritoneal neoplasm, Fallopian tube cancer, Ovarian cancer, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
